Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Heffler

Showing results (21-30 of 313) with videos related to

Pageof 32
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|March 5, 2017
Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumabEnrico Heffler, Silvia Fichera, Giuliana Nicolosi, et al.
Advances in Therapy|January 4, 2025
Costs of Oral Corticosteroid Use in Patients with Severe Asthma With/Without Chronic Rhinosinusitis with Nasal Polyps: Data from the Italian SANI RegistryEnrico Heffler, Francesco Blasi, Pierluigi Paggiaro, et al.
BMJ Case Reports|April 5, 2020
Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgeryLuca Malvezzi, Francesca Pirola, Armando De Virgilio, et al.
Clinical and Translational Allergy|July 2, 2020
Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysisEnrico Heffler, Fabiana Saccheri, Marta Bartezaghi, et al.
Journal of Immunology Research|January 28, 2017
Release of Type 2 Cytokines by Epithelial Cells of Nasal PolypsMonica Boita, Caterina Bucca, Giuseppe Riva, et al.
Current Opinion in Allergy and Clinical Immunology|June 3, 2026
Fractional exhaled nitric oxide and nasal nitric oxide as biomarkers in chronic rhinosinusitisAlessandro Solinas, Ina Zalar, Giovanni Paoletti, et al.
Recenti Progressi in Medicina|February 25, 2006
[Exhaled nitric oxide as a marker of diseases]Giovanni Rolla, Enrico Heffler, Luisa Bommarito, et al.
Expert Opinion on Biological Therapy|April 30, 2019
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?Francesco Menzella, Manuela Latorre, Patrizia Ruggiero, et al.
Current Medicinal Chemistry|July 15, 2020
An Emerging Role for Exhaled Nitric Oxide in Guiding Biological Treatment in Severe AsthmaGiovanni Rolla, Enrico Heffler, Stefano Pizzimenti, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 21, 2015
Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinicEnrico Heffler, Stefano Pizzimenti, Giuseppe Guida, et al.
Pageof 32

Showing results (21-30 of 313) with videos related to

Sort By:
Pageof 32
The Journal of Allergy and Clinical Immunology. in Practice|March 5, 2017
Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumabEnrico Heffler, Silvia Fichera, Giuliana Nicolosi, et al.
Advances in Therapy|January 4, 2025
Costs of Oral Corticosteroid Use in Patients with Severe Asthma With/Without Chronic Rhinosinusitis with Nasal Polyps: Data from the Italian SANI RegistryEnrico Heffler, Francesco Blasi, Pierluigi Paggiaro, et al.
BMJ Case Reports|April 5, 2020
Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgeryLuca Malvezzi, Francesca Pirola, Armando De Virgilio, et al.
Clinical and Translational Allergy|July 2, 2020
Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysisEnrico Heffler, Fabiana Saccheri, Marta Bartezaghi, et al.
Journal of Immunology Research|January 28, 2017
Release of Type 2 Cytokines by Epithelial Cells of Nasal PolypsMonica Boita, Caterina Bucca, Giuseppe Riva, et al.
Current Opinion in Allergy and Clinical Immunology|June 3, 2026
Fractional exhaled nitric oxide and nasal nitric oxide as biomarkers in chronic rhinosinusitisAlessandro Solinas, Ina Zalar, Giovanni Paoletti, et al.
Recenti Progressi in Medicina|February 25, 2006
[Exhaled nitric oxide as a marker of diseases]Giovanni Rolla, Enrico Heffler, Luisa Bommarito, et al.
Expert Opinion on Biological Therapy|April 30, 2019
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?Francesco Menzella, Manuela Latorre, Patrizia Ruggiero, et al.
Current Medicinal Chemistry|July 15, 2020
An Emerging Role for Exhaled Nitric Oxide in Guiding Biological Treatment in Severe AsthmaGiovanni Rolla, Enrico Heffler, Stefano Pizzimenti, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 21, 2015
Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinicEnrico Heffler, Stefano Pizzimenti, Giuseppe Guida, et al.
Pageof 32